Journal of Capital Medical University ›› 1993, Vol. 14 ›› Issue (3): 196-199.

• 论著 • Previous Articles     Next Articles

Treatment of Ischemic Cerebrovascular Disease with Lumbrokinase:An Observation of Therapeutic Effectiveness

Pang Shiqi, Ding Mingchen, Xie Shuping, Chai Xiqing   

  1. Department of Neurology, Xuanwu Hospital, Capital Institute of Medicine
  • Received:1992-04-13 Revised:1900-01-01 Online:1993-07-15 Published:1993-07-15

Abstract: Lumbrokinase is a new antithrombotic drug.We have treated 223 patients with cerebral infarction using this drug.Random sampling and double blind method were adopted.The re-sults revealed that the total effective rate was 93.72%,with the obvious effective rate being 70.40%.Fibrogen,euglobulin lysis time,blood viscosity,plasma viscosity and platelet aggre-gating function were reduced in the treated group.The side effect hasn't be found,thus, lumbrokinase is a nontoxic and safe drug.

Key words: lumbrokinase, antithrombosis, cerebral infarction

CLC Number: